332 related articles for article (PubMed ID: 25711464)
1. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
Pack-Mabien A; Brown B; Herbert DE; Haynes J
J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
[TBL] [Abstract][Full Text] [Related]
2. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
3. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
Ballas SK
Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
[TBL] [Abstract][Full Text] [Related]
4. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Fung EB; Harmatz PR; Milet M; Balasa V; Ballas SK; Casella JF; Hilliard L; Kutlar A; McClain KL; Olivieri NF; Porter JB; Vichinsky EP;
Transfusion; 2008 Sep; 48(9):1971-80. PubMed ID: 18513257
[TBL] [Abstract][Full Text] [Related]
5. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
6. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
Cancado R; Watman NP; Lobo C; Chona Z; Manzur F; Traina F; Park M; Drelichman G; Zarate JP; Marfil L
Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
[TBL] [Abstract][Full Text] [Related]
7. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
9. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
11. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
13. Severe cardiac iron toxicity in two adults with sickle cell disease.
Oduor H; Minniti CP; Brofferio A; Gharib AM; Abd-Elmoniem KZ; Hsieh MM; Tisdale JF; Fitzhugh CD
Transfusion; 2017 Mar; 57(3):700-704. PubMed ID: 28019032
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
[TBL] [Abstract][Full Text] [Related]
15. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion.
Tavares AHJ; Benites BD; Fertrin KY
Transfus Med Rev; 2019 Jul; 33(3):170-175. PubMed ID: 31153715
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
19. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
Hilliard LM; Williams BF; Lounsbury AE; Howard TH
Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
Ishihara A; Yamauchi T; Ikeda K; Fukuyoshi Y; Yokoyama T; Yonemura Y; Uchiba M; Matsui H
Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
